miércoles, 7 de marzo de 2018

Press Announcements > FDA approves new HIV treatment for patients who have limited treatment options

Press Announcements > FDA approves new HIV treatment for patients who have limited treatment options









Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV).Trogarzo is administered intravenously once every 14 days by a trained medical professional and used in combination with other antiretroviral medications. Continue reading.

No hay comentarios: